ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
23 announcements
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
Bandaram Pharma Packtech will hold a board meeting on 29 October 2026 to consider September 2026 quarter results. The trading window stays closed until 16 November 2026.
Bandaram Pharma Packtech Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a standard periodic regulatory disclosure of the company's shareholding structure.
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech submitted its Annual Report and notice for the AGM, which is now rescheduled for September 24, 2026.
Bandaram Pharma Packtech re-appointed its statutory auditor for 36 months and an independent director for a 60-month term, both approved in the board meeting.
Bandaram Pharma Packtech Ltd reported revenue from operations of ₹24 Cr (+196.3% YoY) and net profit of ₹0.7 Cr for Q1 FY27.
Bandaram Pharma Packtech will hold a board meeting on August 13, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Bandaram Pharma Packtech Ltd submitted its quarterly shareholding pattern for the quarter ended June 30, 2026, in compliance with SEBI regulations.
Bandaram Pharma Packtech clarifies no price-sensitive events caused recent share price rise. Company assures prompt disclosure if any future events occur.
Bandaram Pharma Packtech's subsidiary received two work orders worth Rs.27.71 Crore from Government of Telangana. The orders for textbook printing and distribution are to be executed by August 2026.
Mr. NSK Aakarsh Raj resigned as Whole-time Director of Bandaram Pharma Packtech Limited effective June 5, 2026. The departure was cited for personal and professional reasons.
Bandaram Pharma Packtech Ltd reported revenue from operations of ₹26.3 Cr (+209.4% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q4 FY26.
Bandaram Pharma Packtech Limited reported audited financial results for the year ended March 31, 2026. The Board also appointed M/s. MGR & Co. as internal auditors.
Bandaram Pharma Packtech's subsidiary secured a ₹3.87 Crore order from M/s S. A. Printers. The contract involves supplying textbook printing materials through August 2026.
Bandaram Pharma Packtech's subsidiary secured a ₹5.87 Crore order from Vijayaa Print Solutions. The contract for textbook material supply strengthens short-term revenue visibility.
Bandaram Pharma Packtech's subsidiary secured textbook printing orders worth ₹37.44 Crore from the Telangana government. The project will be executed between June and August 2026.
Bandaram Pharma Packtech scheduled a board meeting for May 30, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Bandaram Pharma Packtech Limited submitted its annual disclosure confirming it does not meet the criteria for 'Large Corporate' identification for FY 2025-26. Consequently, mandatory borrowing through debt securities is not applicable. This is a routine regulatory compliance filing under the SEBI Large Corporate framework.
Bandaram Pharma Packtech Ltd informed BSE that it does not qualify as a 'Large Corporate' for FY 2026-27. The company reported outstanding borrowings of ₹3.48 Crore as of March 31, 2026, which is below the ₹1,000 Crore threshold required for the mandatory SEBI debt-borrowing framework.
Bandaram Pharma Packtech Ltd reported net profit of ₹0.3 Cr for Q3 FY26.
Bandaram Pharma Packtech's board approved material related party transactions with its subsidiary, VSR Paper and Packaging. An EGM is scheduled for April 27, 2026, to regularise Additional Director Mr. Eswar Reddy Putturu and seek shareholder approval for these transactions.